{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-036165","form_type":"8-K","ticker":"CCEL","cik":"0000862692","company_name":"CRYO CELL INTERNATIONAL INC","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.077522+00:00","generated_at":"2026-06-04T08:15:13.375867+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cryo-Cell plans spin-off of Celle Corp. and explores strategic alternatives including sale","bullets":["Board authorized spin-off of newly formed Celle Corp. via stock dividend to Cryo-Cell shareholders.","Spin-off expected in Q2 or Q3 2024; Celle Corp. holds Duke University license and other assets.","Company will explore equity/debt financings or possible sale/merger for post-spin-off Cryo-Cell.","No assurance that any transaction will occur; further details to be disclosed in SEC filings."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-036165","json":"https://secwatch.observer/filing/0000950170-24-036165.json","markdown":"https://secwatch.observer/filing/0000950170-24-036165.md","text":"https://secwatch.observer/filing/0000950170-24-036165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862692/000095017024036165/0000950170-24-036165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862692/000095017024036165/ccel-20240325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:15:13.375867+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}